Objectives-To examine the use of thrombolytic treatment in patients with suspected acute myocardial infarction (AMI) and left bundle branch block (LBBB). To evaluate electrocardiographic criteria for the identification of AMI in the presence of LBBB, and examine the implications of using these criteria in the clinical setting. Methods-A retrospective study over two years, based in two Sheffield teaching hospitals. Patients presenting with LBBB and suspected AMI were studied by analysis of an AMI database. The proportion of patients with LBBB and AMI receiving thrombolysis, and the in-hospital delay before the start of treatment, were used as indicators of current performance.
patients with LBBB and AMI did not receive thrombolysis, in the absence of documented contraindications. The mean in-hospital treatment delay for thrombolysed patients was 154 minutes. Forty eight per cent (16/33) of those thrombolysed did not have a final clinical diagnosis of AMI. In the majority of cases (8/12) , the decision not to administer thrombolysis was based on a single ECG recording.
The presence of any of the predictive electrocardiographic criteria was associated with a diagnosis ofAMI, with a sensitivity of 0.79 (95% confidence interval 0.63 to 0.95), specificity 1, positive predictive value 1, and negative predictive value 0.79. The K scores between four independent observers showed either substantial or near perfect agreement.
Conclusion-Currently, thrombolytic treatment is under-utilised in patients with LBBB and AMI, and those who are thrombolysed endure lengthy delays before treatment. Patients with any of the predictive criteria should be throm- The purpose of our study was to examine the current local management of patients presenting with chest pain and LBBB, to evaluate the predictive electrocardiographic criteria,20 and to assess their potential effect on patient care.
Methods
We performed a retrospective study over a two year period based in two Sheffield teaching hospitals. All patients presenting with ischaemic sounding chest pain were identified prospectively and followed up until discharge, and those eligible for thrombolytic treatment were entered on a database.
Patients presenting with suspected AMI and complete LBBB were studied retrospectively. Complete LBBB was defined as: (1) QRS duration of >0.120 seconds in the presence of a supraventricular rhythm; (2) broad and notched or slurred R in I and V5 or V6; (3) absence of Q wave in I and V5 and V6; (4) R wave peak time >0.060 seconds in V5 or V6.
We noted the following: * Whether thrombolytic treatment was administered. * If thrombolysis was not administered, any reason recorded in the case notes. * The interval between arrival at hospital and start of thrombolysis, or "door to needle" time. * The results of serum creatine kinase estimations, on days 1, 2, and 3. All ECGs recorded during admission were obtained. A diagnosis of AMI was established on the basis of a peak creatine kinase value of at least 400 IU/1, or if unavailable, on the results of postmortem examination. Other serum markers of myocardial injury were not collected routinely.
The presenting ECGs were reviewed blindly, and the clinical prediction rule20 was used to estimate the probability of AMI, each patient being awarded a score between 0 and 10. The actual clinical diagnosis was then compared 
Conclusion
Thrombolytic treatment significantly reduces mortality in AMI with LBBB, particularly if given early, and the magnitude of the benefit justifies the administration of thrombolysis to all patients with LBBB and suspected AMI. However, thrombolysis remains under-utilised in patients with LBBB, and those who do receive it have long door to needle times. The under-utilisation of thrombolysis and long door to needle times may reflect a reluctance to expose patients to the risks of thrombolytic drugs without a confident diagnosis of AMI.
Attempts to validate the electrocardiographic criteria have so far been flawed, and a prospective study, using serial ECGs when appropriate, is needed to establish their true sensitivity. On the strength of current evidence, the decision to withhold thrombolysis should not be based solely on the absence of these criteria.
The described criteria can reliably identify the majority of patients with AMI. The presence of any of the criteria in a patient with LBBB and suspected AMI warrants immediate thrombolysis; searches for old ECGs unnecessarily prolong the door to needle time. Application of the criteria could significantly reduce in-hospital treatment delays for many patients. Patients in whom the diagnosis is in doubt require serial ECGs in case of evolving ischaemic change. I group.bmj.com on July 2, 2017 -Published by http://emj.bmj.com/ Downloaded from
